Cargando…
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
CONTEXT: The burden of cirrhosis from nonalcoholic fatty liver disease (NAFLD) is reaching epidemic proportions in the United States. This calls for greater awareness among endocrinologists, who often see but may miss the diagnosis in adults with obesity or type 2 diabetes mellitus (T2D) who are at...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684453/ https://www.ncbi.nlm.nih.gov/pubmed/34406410 http://dx.doi.org/10.1210/clinem/dgab578 |